Published in PLoS One on May 13, 2015
Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Oncotarget (2016) 0.77
Carbon Monoxide Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by the cGMP/PKG and NF-κB Signaling Pathway. J Virol (2016) 0.75
MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2. Am J Cancer Res (2016) 0.75
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals. Anticancer Agents Med Chem (2016) 0.75
Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues. J Cancer (2016) 0.75
Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data. Sci Rep (2016) 0.75
Plasma miR-187* is a potential biomarker for oral carcinoma. Clin Oral Investig (2016) 0.75
miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma. Exp Ther Med (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell (2006) 14.70
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2006) 9.91
Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci U S A (1996) 8.10
A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods (2006) 7.00
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells (2011) 2.75
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res (2010) 2.39
Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics (1982) 1.74
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells (2012) 1.70
The microRNA pathway and cancer. Cancer Sci (2010) 1.66
Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol (1996) 1.46
MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene (2011) 1.31
Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics (2009) 1.28
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J Urol (2014) 1.11
Aldehyde dehydrogenase gene superfamily: the 2000 update. Chem Biol Interact (2001) 0.94
Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP. Exp Biol Med (Maywood) (2007) 0.91
miRNAs as biomarkers in prostate cancer. Clin Transl Oncol (2012) 0.90
Effect of retinoic acid on prostatic development. Prostate (1997) 0.87
Profiling of microRNA in human and mouse ES and iPS cells reveals overlapping but distinct microRNA expression patterns. PLoS One (2013) 0.87
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J Urol (2014) 1.11
Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy. J Urol (2010) 0.92
Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer. Eur J Cancer (2014) 0.80
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents. Oncotarget (2015) 0.78